Skip to content

Venous sac embolization for pulmonary arteriovenous malformations using Hydrocoils: a phase II study (SCIRO-1402)

Venous sac embolization for pulmonary arteriovenous malformations using Hydrocoils: a phase II study (SCIRO-1402) - Venous sac embolization for pulmonary arteriovenous malformations using Hydrocoils (SCIRO-1402)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014360
Enrollment
21
Registered
2014-07-01
Start date
2014-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary arteriovenous malformation

Interventions

Following doing pulmonary arteriography, venous sac embolization of pulmonary arteriovenous mulformations is to be performed using Hydrocoil. Embolization is performed in 1 procedure.

Sponsors

Okayama University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Pulmonary arteriovenous malformation exists on chest CT (<= 3mm thickness) 2) Meets one or more following criteria. a) history of brain infarction and/or abscess b) history of transient ischemic attack c) history of hemoptysis d) history of hypoxemia e) diameter of feeding pulmonary artery >= 3mm. 3) Adequate cardiac, hepatic, renal, respiratory, coagulation, and bone marrow functions. 4) Performans status of 0-2. 5) Life expectancy >= 13 months.

Exclusion criteria

Exclusion criteria: 1) History of allergy of iodinated contrast material 2) Active asthma 3) Single lung. 4) Inpaired pulmonary function of contralateral lung. 5) Pulmonary hypertension. 6) Estimated Glomerular Filtration Rate < 30min/mil (excluding dialysis) 7) Child Pugh score >= 9 8) Heart failure (NYHA >= III) 9) Uncontrolable malignant disease. 10) Active infection or active inflammatory process 11) Body temperature of 38 degree or more. 12) Pregnant. 13) Not eligible determined by the responding physician.

Design outcomes

Primary

MeasureTime frame
efficacy

Secondary

MeasureTime frame
adverse event image findings

Countries

Japan

Contacts

Public ContactToshihiro Iguchi

Okayama University Hospital Department of Radiology

iguchi@cc.okayama-u.ac.jp+81-86-235-7315

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026